Cleared Traditional

K863918 - MINOLTA/MARQUEST PULSOX-7 OXYGEN SATURA...

K863918 is an FDA 510(k) clearance for MINOLTA/MARQUEST PULSOX-7 OXYGEN SATURA..., manufactured by Marquest Medical Products, Inc.. The device is a Class 2 Anesthesiology device with product code DQA cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K863918 · Marquest Medical Products, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1987
Decision
91d
Days
Class 2
Risk

K863918 is an FDA 510(k) clearance for the MINOLTA/MARQUEST PULSOX-7 OXYGEN SATURATION MONIT.. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Marquest Medical Products, Inc. (Englewood, US). The FDA issued a Cleared decision on January 7, 1987 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Marquest Medical Products, Inc. devices

FDA 510(k) Submission Details - K863918

510(k) Number K863918 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 08, 1986
Decision Date January 07, 1987
Days to Decision 91 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 140d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQA Device Classification - Class 2, Special Controls

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 447
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K863918.
SATLITE/PB251 PULSE OXIMETER
K870621 · Datex Division Instrumentarium Corp. · Mar 1987
SPACELABS MODEL 90419 PULSE OXIMETER MODULE
K864279 · Spacelabs, Inc. · Mar 1987
BIOCHEM MICROSPAN 1040 OXIMETER
K870163 · Biochem International, Inc. · Mar 1987
ACCUSAT
K863855 · Datascope Corp. · Jan 1987
BIOCHEM CO/OX 1000
K863186 · Biochem International, Inc. · Nov 1986
MODEL 8604 OXYGEN/PULSE MONITOR
K860051 · Nonin Medical, Inc. · Jun 1986